Filing Details

Accession Number:
0001193125-16-739874
Form Type:
13G Filing
Publication Date:
2016-10-17 17:24:02
Filed By:
Banque Degroof Petercam Luxembourg S.a.
Company:
Apyx Medical Corp (NASDAQ:APYX)
Filing Date:
2016-10-17
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Banque Degroof Petercam Luxembourg S.A 0 0 0 0 010 0.0%
Petercam Horizon L Country Sector Discounted Assets 0 0 0 0 010 0.0%
Filing

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

BOVIE MEDICAL CORPORATION

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

10211F100

(CUSIP Number)

March 9, 2016

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒ Rule 13d-1(b)

☐ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 10211F100   13G   Page 2 of 6 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Banque Degroof Petercam Luxembourg S.A. (1)

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

 

(a)  ☐        (b)  ☒

  3.  

SEC USE ONLY

 

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Luxembourg

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

   5.    

SOLE VOTING POWER

 

0

   6.   

SHARED VOTING POWER

 

0

   7.   

SOLE DISPOSITIVE POWER

 

0

   8.   

SHARED DISPOSITIVE POWER

 

0

  9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0

10.  

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.0%

12.  

TYPE OF REPORTING PERSON (see instructions)

 

FI

 

(1) On April 1, 2016, Petercam (Luxembourg) S.A. changed its name to Banque Degroof Petercam Luxembourg S.A.

CUSIP No. 10211F100   13G   Page 3 of 6 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Petercam Horizon L Country & Sector Discounted Assets

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

 

(a)  ☐        (b)  ☒

  3.  

SEC USE ONLY

 

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Luxembourg

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

   5.    

SOLE VOTING POWER

 

0

   6.   

SHARED VOTING POWER

 

0

   7.   

SOLE DISPOSITIVE POWER

 

0

   8.   

SHARED DISPOSITIVE POWER

 

0

  9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0

10.  

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.0%

12.  

TYPE OF REPORTING PERSON (see instructions)

 

FI


CUSIP No. 10211F100   13G   Page 4 of 6 Pages

Item 1.

 

  (a) Name of Issuer

Bovie Medical Corporation

 

  (b) Address of Issuers principal executive offices

4 Manhattanville Road, Suite 106, Purchase, NY 10577

Item 2.

 

  (a) Name of person filing

This Amendment No. 1 to the Schedule 13G filed on March 25, 2016 is being filed on behalf of Banque Degroof Petercam Luxembourg S.A. (Petercam) and Petercam Horizon L Country & Sector Discounted Assets (Horizon L) with respect to the shares of Common Stock, $0.001 par value per share (the Common Stock), of Bovie Medical Corporation, a Delaware corporation.

Petercam acts as investment manager with respect to, and exercises investment discretion with respect to the Common Stock directly owned by, a number of private investment funds, including Horizon L, a Luxembourg corporation.

The filing of this statement should not be construed as an admission that Petercam is, for the purpose of Section 13 of the Act, the beneficial owner of the Common Stock reported herein.

 

  (b) Address or principal business office or, if none, residence

The address of (i) Petercam is 12, Rue Eugène Ruppert, L 2453 Luxembourg and (ii) Horizon L is 14, Boulevard Royal, L-2449 Luxembourg.

 

  (c) Citizenship

See Row 4 of each Cover Page.

 

  (d) Title of class of securities

Common Stock, par value $0.001 per share

 

  (e) CUSIP No.

10211F100

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)      Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)      Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)      Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d)      Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)      An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)      An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)      A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h)      A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

CUSIP No. 10211F100   13G   Page 5 of 6 Pages

 

(i)      A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)      A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
(k)      Group, in accordance with §240.13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution:

Petercam is comparable to an IA and Horizon L is comparable to a CO.

Item 4. Ownership.

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of each Cover Page and is incorporated herein by reference.

Petercam expressly declares that this filing shall not be construed as an admission that it is, for the purposes of Sections 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by this filing.

Item 5. Ownership of 5 Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒.

Item 6. Ownership of More than 5 Percent on Behalf of Another Person.

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not applicable.

Item 8. Identification and Classification of Members of the Group.

Not applicable.

Item 9. Notice of Dissolution of Group.

Not applicable.

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


CUSIP No. 10211F100   13G   Page 6 of 6 Pages

SIGNATURES

After reasonable inquiry and to the best of each of the undersigneds knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

DATED: October 17, 2016

BANQUE DEGROOF PETERCAM LUXEMBOURG S.A.

 

By:  

/s/ Patrick Wagenaar

Patrick Wagenaar, Head of Private Banking
By:   /s/ Dominik Ost
Dominik Ost, Senior Private Banker

PETERCAM HORIZON L COUNTRY & SECTOR DISCOUNTED ASSETS

 

By:  

/s/ Jérôme Castagne

Jérôme Castagne, Director

Exhibit 1

JOINT FILING AGREEMENT

PURSUANT TO SECTION 240.13D-1 (K)

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that it knows or has reason to believe that such information is inaccurate.

BANQUE DEGROOF PETERCAM LUXEMBOURG S.A.

 

By:  

/s/ Patrick Wagenaar

Patrick Wagenaar, Head of Private Banking
By:   /s/ Dominik Ost
Dominik Ost, Senior Private Banker

PETERCAM HORIZON L COUNTRY & SECTOR DISCOUNTED ASSETS

 

By:  

/s/ Jérôme Castagne

Jérôme Castagne, Director